Dr. Frances Dougherty Kendall, MD
- Part D claims, 2024
- 31
- Publications
- 1
- Clinical trials
- 4
- Hospital affiliations
- 1
- Industry payments
- $75
- Practice address
- 1199 Prince Avenue, Athens, GA 30606
- Practice phone
- Call (706) 475-7000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kendall's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Frances Dougherty Kendall is a clinical biochemical genetics physician in Athens, Georgia
Dr. Kendall practices at Piedmont Athens Regional in Athens, Georgia, part of Piedmont Healthcare.
Dr. Kendall's NPI, 1881658300, was assigned on April 13, 2006. Dr. Kendall graduated from Rutgers New Jersey Medical School in 1987. Dr. Kendall holds Georgia license 044706.
- NPI
- 1881658300NPI Registry (opens in a new tab)
- NPI enumeration date
- April 13, 2006
- NPI status
- Active
- Practice phone
- (706) 475-7000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Frances Dougherty Kendall practices at Piedmont Athens Regional in Athens, Georgia
Dr. Kendall's primary practice is Piedmont Athens Regional, at 1199 Prince Avenue, Athens, GA 30606 in Clarke County. The practice phone is (706) 475-7000.
- Piedmont Athens Regional1199 Prince Avenue, Athens, GA 30606 · Clarke CountyPhone(706) 475-7000
Source: Dmand AI Affiliation Data
Dr. Frances Dougherty Kendall is affiliated with 1 site of care
Dr. Kendall's primary practice is Piedmont Athens Regional in Athens, Georgia, part of Piedmont Healthcare.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Frances Dougherty Kendall's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kendall practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Piedmont Athens Regional | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Piedmont Healthcare and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Frances Dougherty Kendall's specialty is clinical biochemical genetics
Clinical biochemical genetics is Dr. Kendall's primary specialty in the NPI Registry, under taxonomy code 207SG0202X. Dr. Kendall is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics. Dr. Kendall is licensed in Georgia.
Specialties and state licenses
- Clinical biochemical genetics, GeorgiaPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Frances Dougherty Kendall's patients have a median age of 33
Across all payers, Dmand AI patient panel data puts Dr. Kendall's median patient age at 33, with 82% women.
Dr. Kendall's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 33
Patient panel by sex, all payers
- Women82%
- Men15%
Source: Dmand AI Patient Panel Data
Dr. Frances Dougherty Kendall wrote 31 Medicare Part D claims in 2024
In 2024, Dr. Kendall wrote 31 Medicare Part D claims. 97% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $5,503 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.
Dr. Kendall's Part D claims by kind of drug, 2024
- Generic30 claims97%
- Brand-name and other1 claims3%
Dr. Kendall's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 292024: 1355%
Drugs named by CMS: 1 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Frances Dougherty Kendall has 1 publication on record
Dmand AI links 1 paper to Dr. Kendall in 2020. Dr. Kendall's most frequent co-author is Vibhash Dinesh Sharma, MD.
Dr. Kendall's most frequent co-authors
Recent publications by Dr. Kendall
See who Dr. Kendall researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kendall works with, so you can find a warm path to the right clinical biochemical genetics physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Frances Dougherty Kendall has worked on 4 clinical trials
Dmand AI links Dr. Kendall to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Mitochondrial Diseases, Leigh Disease and Mitochondrial Myopathies. Stealth BioTherapeutics Inc. sponsors the most, 2.
Clinical trials with Dr. Kendall by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Kendall's trials
- Mitochondrial Diseases
- Leigh Disease
- Mitochondrial Myopathies
- MELAS Syndrome
- Muscular Diseases
Investigators on the most trials with Dr. Kendall
Recent clinical trials with Dr. Kendall
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study (opens in a new tab)
EPI-743 for Metabolism or Mitochondrial Disorders (opens in a new tab)
EPI-743 for Mitochondrial Respiratory Chain Diseases (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Frances Dougherty Kendall received $75 in industry payments from 2016 to 2023
CMS Open Payments shows 4 general payments to Dr. Kendall from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 68% of the total. Sarepta Therapeutics, Inc. paid the most, $26.
General payments to Dr. Kendall by program year, 2016 to 2023
General payments to Dr. Kendall by kind, 2016 to 2023
- Food and beverage$5168%
- Education$2432%
Companies that paid Dr. Kendall the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Frances Dougherty Kendall has 1 award and honors on record
Dmand AI lists 1 award for Dr. Kendall, most recently Making a Difference in Mitochondrial Medicine in 2012. Dr. Kendall serves on United Mitochondrial Disease Foundation Regional Champion and MitoAction Medical Advisory Board.
Awards and honors for Dr. Kendall
- 2012
- Making a Difference in Mitochondrial Medicine
Dr. Kendall's committees and leadership roles
- United Mitochondrial Disease Foundation Regional ChampionProfessional Representative
- 2010 to present
- MitoAction Medical Advisory BoardMember
- 2009 to present
Source: Dmand AI Professional Profile Data
Dr. Frances Dougherty Kendall graduated from Rutgers New Jersey Medical School
Dr. Kendall graduated from Rutgers New Jersey Medical School in 1987.
- Medical school
- Board certified in clinical biochemical genetics
Source: Dmand AI Professional Profile Data
Sources for Dr. Frances Dougherty Kendall's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Frances Dougherty Kendall
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Frances Dougherty Kendall's NPI number?
Dr. Frances Dougherty Kendall's NPI number is 1881658300. It was assigned on April 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Frances Dougherty Kendall?
Dr. Frances Dougherty Kendall is a clinical biochemical genetics physician in Athens, Georgia. The primary specialty in the NPI Registry is Clinical Biochemical Genetics Physician (taxonomy code 207SG0202X).
Where does Dr. Frances Dougherty Kendall practice?
Dr. Kendall practices at 1199 Prince Avenue, Athens, GA 30606. Dr. Kendall's primary practice is Piedmont Athens Regional in Athens, Georgia, part of Piedmont Healthcare.
What is Dr. Frances Dougherty Kendall's office phone number?
The practice phone on file for Dr. Kendall is (706) 475-7000.
What is Dr. Frances Dougherty Kendall's medical license number?
Dr. Kendall holds Georgia license 044706.
Which hospitals is Dr. Frances Dougherty Kendall affiliated with?
Dr. Kendall practices at Piedmont Athens Regional in Athens, Georgia.
Is Dr. Frances Dougherty Kendall board certified?
Yes. Dr. Kendall is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics.
Where did Dr. Frances Dougherty Kendall go to medical school?
Dr. Kendall graduated from Rutgers New Jersey Medical School in 1987.
What drugs does Dr. Frances Dougherty Kendall prescribe most?
In 2024 Medicare Part D data, Dr. Kendall's most prescribed drugs by claims were Leucovorin Calcium.
Has Dr. Frances Dougherty Kendall received payments from drug or device companies?
CMS Open Payments shows $75 in general payments to Dr. Kendall from 3 companies from 2016 to 2023. The largest total came from Sarepta Therapeutics, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Frances Dougherty Kendall been practicing?
Dr. Kendall graduated from medical school in 1987, 39 years ago.
Does Dr. Frances Dougherty Kendall do research?
Dmand AI links 1 publication to Dr. Kendall. Dr. Kendall has worked on 4 clinical trials.
Who does Dr. Frances Dougherty Kendall publish with?
Dr. Kendall's most frequent co-authors are Vibhash Dinesh Sharma, MD (1 shared paper).
Selling to clinical biochemical genetics practices?
See clinical biochemical genetics physicians in Georgia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card